From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS.
Laughon
B E
BE
Developmental Therapeutics Branch, NIAID, NIH, Bethesda, MD 20892.
Allaudeen
H S
HS
Becker
J M
JM
Current
W L
WL
Feinberg
J
J
Frenkel
J K
JK
Hafner
R
R
Hughes
W T
WT
Laughlin
C A
CA
Meyers
J D
JD
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000150:complications / Q000188:drug therapy; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy; D009181:Mycoses / Q000150:complications / Q000188:drug therapy; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy; D014123:Toxoplasmosis / Q000150:complications / Q000188:drug therapy
D000890:Anti-Infective Agents